« Back to Infections and Infestations

Hansen’s Disease (Leprosy)

»What causes leprosy?
»Why is leprosy called Hansen’s disease?
»How is leprosy transmitted?
»Are children and adults equally susceptible to acquiring leprosy?
»Are humans the only host for M. leprae?
»Is leprosy a systemic disease?
»How common is leprosy?
»Are there endemic areas for leprosy in the United States?
»How is leprosy recognized clinically?
»Is there more than one kind of leprosy?
»Does indeterminate leprosy mean that you do not know what type it is?
»What are the two “polar” forms of leprosy? How do they differ?
»Describe dimorphous leprosy.
»What is the unusual feature of the cell-mediated immunity in lepromatous leprosy?
»Define the cytokine response to M. leprae in tuberculoid versus lepromatous patients.
»How is the diagnosis of leprosy usually made?
»What area should be biopsied to detect M. leprae?
»Can the same acid-fast stain used for Mycobacterium tuberculosis be used for the leprosy bacillus?
»What are Virchow cells?
»Is the lepromin skin test helpful in making a diagnosis of leprosy?
»Is the neuropathy in lepromatous leprosy the same as that in diabetic neuropathy?
»Describe a patient with advanced lepromatous leprosy.
»What are the most common complications in leprosy?
»What are the reactional states of leprosy?
»What drugs are used in multidrug therapy for leprosy?
»Do the recommendations of the World Health Organization (WHO) differ from those of the U.S.?
»What are the side effects of the drugs for leprosy treatment?
»What is the most bothersome cutaneous side effect of clofazimine?
»How are the reactional states of leprosy treated?
»Should family members of leprosy patients be treated?
»Can leprosy be eliminated as a worldwide disease, as smallpox has been?

 
 
 

What are the reactional states of leprosy?


Erythema nodosum leprosum. The reactive state in lepromatous leprosy resembles erythema nodosum but may be bullous, as seen in this patient.
Fig. 29.6 Erythema nodosum leprosum. The reactive state in lepromatous leprosy resembles erythema nodosum but may be bullous, as seen in this patient.
There are two types of reactions that may occur spontaneously but often follow the initiation of antibacterial therapy by months to years. Approximately half of all leprosy patients experience one of these acute inflammatory episodes at some point in their disease course.

Type I reactions (reversal reactions) complicate unstable dimorphous leprosy and represent alterations in the patient’s cell-mediated immunity. The immunity may be either upgraded or downgraded. Typically, in type I reactions, existing lesions become acutely inflamed.

Type II reactions (most commonly erythema nodosum leprosum [ENL]) occur in lepromatous leprosy (Fig. 29-6). ENL reactions are believed to represent immune complex precipitation in blood vessels due to released antigens from M. leprae organisms that have been damaged by antibiotic therapy. The patients develop red, tender nodules mainly on their extremities, associated with constitutional symptoms including fever, arthralgias, lymphadenitis, and neuritis.

Burdick AE: Leprosy including reactions. In Lebwohl M, Heymann WR, Berth-Johnes J, Coulson I, editors: Treatment of skin disease, New York, 2002, Mosby, pp 336–339.